SAN FRANCISCO & EMERYVILLE, Calif. & PARIS--(BUSINESS WIRE)--The Institute for OneWorld Health (iOWH), the U.S.-based nonprofit pharmaceutical company, together with synthetic biology innovator Amyris ...

NEW YORK (AP) -- Shares of Amyris Inc. rose Thursday after Amyris' partner, French drugmaker Sanofi, started large-scale production of a malaria treatment using technology Amyris developed. Sanofi ...

Twelve years after a breakthrough discovery in his University of California, Berkeley, laboratory, professor of chemical engineering Jay Keasling is seeing his dream come true. On April 11, the ...

The nonprofit Institute for OneWorld Health in San Francisco, Emeryville's Amyris Biotechnologies and the French pharmaceutical company Sanofi-Aventis have agreed to develop a key synthetic ingredient ...

An Emeryville biotech company that gained fame creating a more affordable cure for malaria has turned to its next challenge, making clean fuel for the world’s cars, trucks, jets and generators.

EMERYVILLE, Calif. and MADRID, Spain, Oct. 23, 2018 (GLOBE NEWSWIRE) -- At the prestigious CPhI Pharma Awards Gala held October 9, in Madrid, Ipca Laboratories, Ltd. was awarded the 2018 CPhI Pharma ...

Stability begins to trickle in this year The world will soon be transformed from a place that talks about producing a wide-range of biobased chemicals on a large scale to one that actually produces ...

All start-up firms in green chemistry dream big, but few dream quite as big as Amyris. Officials at the Emeryville, Calif.-based company want to be known for more than just their flagship product, ...

The best therapy today for malaria is a drug combination that includes a derivative of artemisinin, now solely available from plants grown in Asia and Africa. On Apr. 11, the first semi-synthetic ...